Moderna, Inc. is a Massachusetts-based biotechnology company that develops vaccines and other medicines. Its filings show it lobbies Congress on vaccine-related matters, including vaccine safety and approval, the Vaccine Injury Compensation Program (VICP), pandemic preparedness law reauthorization, and bivalent vaccines. It reported $200,000 across four filings and used Avenue Solutions to lobby.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
TRACY SPICER
The latest disclosures for this client.
AVENUE SOLUTIONS
Q2AVENUE SOLUTIONS
Q1The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
AVENUE SOLUTIONS
MATTHEW FUENTES
AVENUE SOLUTIONS
AVENUE SOLUTIONS
Q4AVENUE SOLUTIONS
Q3AVENUE SOLUTIONS
Q2AVENUE SOLUTIONS
Q1